P

Philip Scheltens

Partner, Head of Dementia Fund
💼 Partner at EQT Life Sciences →
About

Philip Scheltens is a Partner and Head of the Dementia Fund at EQT Life Sciences. He is listed as the responsible advisor for NewAmsterdam Pharma, a late-stage biopharmaceutical company focused on metabolic diseases and investigating obicetrapib as a potential treatment for Alzheimer’s disease.

Focus Areas

BioTech, HealthTech, Dementia

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account · Get started in 1-click